The A4 study: Now is the time to join the fight to prevent Alzheimer's disease.

Day

August 17, 2021

Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial

August 17, 2021
Off
Ngolab J, Donohue M, Belsha A, et al. Alzheimer’s & dementia: diagnosis, assessment & disease monitoring; Alzheimers Dement (Amst). 2021;13(1):e12199-n/a.
READ MORE

Feasibility Study Conducted for A4 Trial

August 17, 2021
Off
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
READ MORE

A4 Study Organizers

The A4 Study is a landmark public-private partnership, funded by the National Institute on Aging/NIH, Eli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the University of Southern California’s Alzheimer’s Therapeutic Research Institute, with study sites in multiple locations.

Quick Search

Share the A4 Study

©2019 A4 Study

Your upload was successful!